Jacob Corn is the Professor of Genome Biology at ETH Zürich. His research aims to bring about the end of genetic disease through the development and application of next-generation genome editing technologies. Jacob is committed to the improvement of human health through the fundamental understanding of disease mechanisms. Over the last fifteen years he has bridged academia and industry, working in therapeutic areas that include infectious disease, neurobiology, and oncology. His graduate studies at the University of California, Berkeley redefined our understanding of DNA replication and his postdoctoral work at the University of Washington computationally designed protein inhibitors from scratch. Jacob was a group leader at Genentech where he discovered biological mechanisms for challenging therapeutic targets. Prior to joining ETHZ, Jacob was the founding Scientific Director of the Innovative Genomics Institute and faculty at UC Berkeley.